0001104659-19-031226.txt : 20190522
0001104659-19-031226.hdr.sgml : 20190522
20190522213759
ACCESSION NUMBER: 0001104659-19-031226
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190522
FILED AS OF DATE: 20190522
DATE AS OF CHANGE: 20190522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SVLSF V, LLC
CENTRAL INDEX KEY: 0001644160
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38916
FILM NUMBER: 19847789
BUSINESS ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
BUSINESS PHONE: 617-367-8100
MAIL ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SV LIFE SCIENCES FUND V LP
CENTRAL INDEX KEY: 0001460732
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38916
FILM NUMBER: 19847790
BUSINESS ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
BUSINESS PHONE: 617-973-2708
MAIL ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SV Life Sciences Fund V (GP), LP
CENTRAL INDEX KEY: 0001644146
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38916
FILM NUMBER: 19847791
BUSINESS ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
BUSINESS PHONE: 617-367-8100
MAIL ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SV Life Sciences Fund V Strategic Partners, L.P.
CENTRAL INDEX KEY: 0001482194
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38916
FILM NUMBER: 19847792
BUSINESS ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
BUSINESS PHONE: 617-973-2708
MAIL ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS Ltd
CENTRAL INDEX KEY: 0001761612
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
BUSINESS PHONE: 011441223261503
MAIL ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
3
1
a3.xml
3
X0206
3
2019-05-22
0
0001761612
BICYCLE THERAPEUTICS Ltd
BCYC
0001644160
SVLSF V, LLC
C/O BICYCLE THERAPEUTICS PLC
B900, BABRAHAM RESEARCH CAMPUS
CAMBRIDGE
X0
CB22 3AT
UNITED KINGDOM
0
0
1
0
0001460732
SV LIFE SCIENCES FUND V LP
C/O BICYCLE THERAPEUTICS PLC
B900, BABRAHAM RESEARCH CAMPUS
CAMBRIDGE
X0
CB22 3AT
UNITED KINGDOM
0
0
1
0
0001644146
SV Life Sciences Fund V (GP), LP
C/O BICYCLE THERAPEUTICS PLC
B900, BABRAHAM RESEARCH CAMPUS
CAMBRIDGE
X0
CB22 3AT
UNITED KINGDOM
0
0
1
0
0001482194
SV Life Sciences Fund V Strategic Partners, L.P.
C/O BICYCLE THERAPEUTICS PLC
B900, BABRAHAM RESEARCH CAMPUS
CAMBRIDGE
X0
CB22 3AT
UNITED KINGDOM
0
0
1
0
Series A Preferred Shares
Ordinary Shares
874709
I
By SV Life Sciences Fund V, L.P.
Series B1 Preferred Shares
Ordinary Shares
623196
I
By SV Life Sciences Fund V, L.P.
Series A Preferred Shares
Ordinary Shares
18485
I
By SV Life Sciences Fund V Strategic Partners L.P.
Series B1 Preferred Shares
Ordinary Shares
13169
I
By SV Life Sciences Fund V Strategic Partners L.P.
Each share of Series A Preferred and Series B1 Preferred shall automatically convert into Ordinary shares on a one for 1.429 basis immediately prior to the closing of the Issuer's initial public offering of Ordinary Shares and have no expiration date.
Share numbers give effect to the bonus shares issued to each holder of ordinary shares on the basis of 1.429 bonus shares for each ordinary share in issue, effective on May 13, 2019, which will be effective for the ordinary shares upon their conversion to ordinary shares upon the closing of the Issuer's initial public offering. The number of shares reflects the conversion of the Series A Preferred Shares and Series B1 Preferred Shares to Ordinary Shares set out in footnote (1) above.
These shares are owned directly by SV Life Sciences Fund V, L.P. ("SVLS V LP"). SV Life Sciences Fund V (GP), LP ("SVLS V GP") is the general partner of SVLS V LP. The general partner of SVLS V GP is SVLSF V, LLC. Kate Bingham, Eugene D. Hill, III and Michael J. Ross are members of the investment committee of SVLSF V, LLC. SVLS V GP, SVLSF V, LLC and each of the individuals comprising the SVLSF V, LLC investment committee may be deemed to share voting, dispositive and investment power over the shares held of record by SVLS V LP. Each of SVLS V GP, SVLSF V, LLC and the individual members of the SVLSF V, LLC investment committee disclaims beneficial ownership of these securities and this report shall not be deemed to be an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or any other purpose, except to the extent of their pecuniary interest therein.
These shares are owned directly by SV Life Sciences Fund V Strategic Partners L.P. ("SVLS V SPP"). SVLS V GP is the general partner of SVLS V SPP. The general partner of SVLS V GP is SVLSF V, LLC. Kate Bingham, Eugene D. Hill, III and Michael J. Ross are members of the investment committee of SVLSF V, LLC. SVLS V GP, SVLSF V, LLC and each of the individuals comprising the SVLSF V, LLC investment committee may be deemed to share voting, dispositive and investment power over the shares held of record by SVLS V SPP. Each of SVLS V GP, SVLSF V, LLC and the individual members of the SVLSF V, LLC investment committee disclaims beneficial ownership of these securities and this report shall not be deemed to be an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or any other purpose, except to the extent of their pecuniary interest therein
SVLSF V, LLC By: /s/ Brent M. Faduski Name:Brent M. Faduski Title:Officer
2019-05-22
SV LIFE SCIENCES FUND V, L.P. By: /s/ Brent M. Faduski Name:Brent M. Faduski Title:SVLSF V, LLC Officer
2019-05-22
SV LIFE SCIENCES FUND V (GP), L.P. By: /s/ Brent M. Faduski Name:Brent M. Faduski Title:SVLSF V, LLC Officer
2019-05-22
SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P. By: /s/ Brent M. Faduski Name:Brent M. Faduski Title:SVLSF V, LLC Officer
2019-05-22